Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Continuous processing optimization with smarter tools
Barbara Paldus, Ph.D.
Vice President & General Manager Finesse, part of Thermo Fisher Scientific
A SMART Platform for Scalable Biotherapeutic Development: cDNA to 200L Single-Use Stirred-Tank Bioreactor
Trends in Single-Use Mixing Technologies and Insight into Pall and Lonza Ibex® Solutions
Current Status of Analytical Techniques for Characterization of Protein Stability
Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning
View All Featured ArticlesHeadline News
Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis
FDA approves Abbott’s Amplatzer Paraclose device for heart valve leaks
Roche launches VENTANA BAP1 test to support mesothelioma diagnosis
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Advanced process development using automated micro bioreactors shortens timelines and provides process solutions for a rapid scale up
Presented by Presented by Dr. Jincai Li, Vice President of WuXi Biologics and Liang Tang, PhD, Vice President of WuXi Biologics and Sunil Chhatre, Sartorius Stedim Biotech
14th September 2018
Operational Excellence in Process Development in Drug Substance Production
Presented by Ken Green, Ph.D, Head of Manufacturing, Science and Technology at Samsung Biologics, Klaus Mauch, CEO at Insilico Biotechnology AG
11th February 2021
UNICAN: Dual capability in single use bioreactors
Presented by Presented by Ekta Mahajan, Senior. Regulatory Program Director at Genentech
13th October 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Strategy Emerging Markets for Risk Mitigation
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
